BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

268 related articles for article (PubMed ID: 4351493)

  • 1. Secondary hyperparathyroidism.
    Rasmussen H
    Mt Sinai J Med; 1973; 40(3):462-73. PubMed ID: 4351493
    [No Abstract]   [Full Text] [Related]  

  • 2. Renal disease and disorders of calcium metabolism.
    Kanis JA
    Compr Ther; 1978 Aug; 4(8):44-50. PubMed ID: 688743
    [No Abstract]   [Full Text] [Related]  

  • 3. Calcium and skeletal metabolism.
    Deftos LJ; Roos BA; Parthemore JG
    West J Med; 1975 Dec; 123(6):447-58. PubMed ID: 1105981
    [No Abstract]   [Full Text] [Related]  

  • 4. Hyperparathyroidism in idiopathic hypercalciuria: primary or secondary?
    Coe FL; Canterbury J; Reiss E
    Trans Assoc Am Physicians; 1971; 84():152-61. PubMed ID: 5164300
    [No Abstract]   [Full Text] [Related]  

  • 5. [Pathogenesis of secondary hyperparathyroidism and renal bone disease].
    Ito H; Kinugasa E
    Clin Calcium; 2004 May; 14(5):720-5. PubMed ID: 15577032
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Study of the secondary hyperparathyroidism in vitamin D deficiency rickets. I. Aspects of mineral metabolism.
    Viansel M; Manderlier T; Corvilain J; Vis HL
    Biomedicine; 1974 Sep; 21(9):368-71. PubMed ID: 4457157
    [No Abstract]   [Full Text] [Related]  

  • 7. The pathogenesis of secondary hyperparathyroidism of renal failure. Is there a controversy?
    Massry SG; Ritz E
    Arch Intern Med; 1978 May; 138 Spec No():853-6. PubMed ID: 646573
    [No Abstract]   [Full Text] [Related]  

  • 8. [Hyperparathyroidism in endocrinology and nephrology].
    Martini PF; Segoloni GP; Giachino G; Jeantet A; Triolo G; Mangiarotti G; Giacchino F; Messina M
    Minerva Med; 1977 Aug; 68(38):2667-93. PubMed ID: 333311
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Therapeutic procedures in primary and secondary hyperparathyroidism or in hypercalcemia].
    Hey D; Schultis K
    Med Welt; 1969 Nov; 48():2655-7. PubMed ID: 5386517
    [No Abstract]   [Full Text] [Related]  

  • 10. Albright's osteodystrophy in a patient with renal hypercalciuria.
    Moses AM; Notman DD
    J Clin Endocrinol Metab; 1979 Nov; 49(5):794-7. PubMed ID: 226562
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [On the clinical aspects and therapy of renal osteopathy].
    Sommerkamp H; Rodeck G; Hupe K
    Bruns Beitr Klin Chir (1971); 1965 Sep; 211(2):222-30. PubMed ID: 5865523
    [No Abstract]   [Full Text] [Related]  

  • 12. Dissociation between the effects of endogenous parathyroid hormone on adenosine 3',5'-monophosphate generation and phosphate reabsorption in hypocalcemia due to vitamin D depletion: an acquired disorder resembling pseudohypoparathyroidism type II.
    Rao DS; Parfitt AM; Kleerekoper M; Pumo BS; Frame B
    J Clin Endocrinol Metab; 1985 Aug; 61(2):285-90. PubMed ID: 2989317
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Current concepts of parathyroid hormone and vitamin D metabolism: perturbations in chronic renal disease.
    Slatopolsky E; Hruska K; Rutherford WE
    Kidney Int Suppl; 1975 Jan; (2):90-6. PubMed ID: 169425
    [No Abstract]   [Full Text] [Related]  

  • 14. Metabolic bone disease in children.
    Steendijk R
    Clin Orthop Relat Res; 1971; 77():247-75. PubMed ID: 4335242
    [No Abstract]   [Full Text] [Related]  

  • 15. FGF23 and mineral metabolism, implications in CKD-MBD.
    Rodríguez M; López I; Muñoz J; Aguilera-Tejero E; Almaden Y
    Nefrologia; 2012 May; 32(3):275-8. PubMed ID: 22592418
    [No Abstract]   [Full Text] [Related]  

  • 16. Guidelines for disorders of mineral metabolism and secondary hyperparathyroidism should not yet be modified.
    Ix JH; Quarles LD; Chertow GM
    Nat Clin Pract Nephrol; 2006 Jun; 2(6):337-9. PubMed ID: 16932455
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 99mTc-pyrophosphate in demonstrating bone disease of parathyroid dysfunction.
    Holmes RA
    J Nucl Med; 1977 Mar; 18(3):309-10. PubMed ID: 190367
    [No Abstract]   [Full Text] [Related]  

  • 18. The cellular basis of metabolic bone disease.
    Rasmussen H; Bordier P
    N Engl J Med; 1973 Jul; 289(1):25-32. PubMed ID: 4575395
    [No Abstract]   [Full Text] [Related]  

  • 19. [K/DOQI clinical practice guidelines for bone metabolism and disease in CKD].
    Sakaguchi T; Akizawa T
    Clin Calcium; 2004 Sep; 14(9):9-14. PubMed ID: 15577103
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Drug insight: vitamin D analogs in the treatment of secondary hyperparathyroidism in patients with chronic kidney disease.
    Brown AJ; Slatopolsky E
    Nat Clin Pract Endocrinol Metab; 2007 Feb; 3(2):134-44. PubMed ID: 17237840
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.